Cited 5 time in
- Title
- Inhibition of TAK1 by kamebakaurin in dendritic cells
- Author(s)
- J Y Kim; H S Kim; Y J Kim; H K Lee; J S Kim; Jong Soon Kang; J T Hong; Y Kim; B Y Hwang; S B Han
- Bibliographic Citation
- International Immunopharmacology, vol. 15, no. 1, pp. 138-143
- Publication Year
- 2013
- Abstract
- Kamebakaurin (KA) has anti-cancer and anti-inflammatory activities through direct inhibition of DNA-binding activity of nuclear factor-kappa B (NF-κB) p50. We suggest here another molecular target of KA by the use of lipopolysaccharide-treated dendritic cells. In cell- and enzyme-based assays, KA directly inhibited autophosphorylation and kinase activity of TAK1, followed by the inhibition of TAK1-downstream signaling cascades, such as IKK phosphorylation-IκBα degradation-nuclear translocation of NF-κB, phosphorylation of MEK3/6-p38 mitogen activated protein kinase (MAPK), and MKK4/7-c-Jun N-terminal kinase MAPK. These results demonstrated that TAK1 might be the direct molecular target of KA.
- Keyword
- KamebakaurinMAPKNF-κBTAK1
- ISSN
- 1567-5769
- Publisher
- Elsevier
- DOI
- http://dx.doi.org/10.1016/j.intimp.2012.11.004
- Type
- Article
- Appears in Collections:
- Ochang Branch Institute > Division of National Bio-Infrastructure > Laboratory Animal Resource & Research Center > 1. Journal Articles
- Files in This Item:
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.